Clinical Trial Update: 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 12-week study evaluating the efficacy and safety of empagliflozin in patients with type 2 diabetes mellitus and hypertension; the trial is completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-06-17